Financhill
Back

Aclaris Therapeutics 10K Form

Buy
62

ACRS
Aclaris Therapeutics

Last Price:
17.42
Seasonality Move:
5.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACRS News And Ratings

See the #1 stock for the next 7 days that we like better than ACRS

ACRS Financial Statistics

Sales & Book Value

Annual Sales: $6.76M
Cash Flow: $-7.97M
Price / Cash Flow: 0
Annual Sales: $3.30
Price / Book: 5.1

Profitability

EPS (TTM): -1.29000
Net Income (TTM): $-82.08M
Gross Margin: $2.05M
Return on Equity: -39.1%
Return on Assets: -31.89%

Aclaris Therapeutics Earnings Forecast

Key Aclaris Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 8 years for ACRS is 30.33%.
  • The Selling, General & Administrative Expenses for ACRS have been equal to 349.41% of Gross Profit Margin.
  • The Research & Development expenses have been 648.08% of Revenue.
  • The Net Earning history of ACRS is -1,344.23% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Aclaris Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostics & Research
Sector: Healthcare
Current Symbol: ACRS
CUSIP: 00461U
Website: aclaristx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.97
Quick Ratio: 12.57

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACRS Technical Analysis vs Fundamental Analysis

Buy
62
Aclaris Therapeutics (ACRS) is a Buy

Is Aclaris Therapeutics a Buy or a Sell?